CONTROLLED BLOOD SUGAR IN PERIOPERATIVE PERIOD, REDUCES LENGTH OF STAY IN CARDIAC ICU
Objective: The aim of this study was to assess the length of stay in Cardiac ICU (intensive care unit) in patients undergoing
cardiac surgery in the two groups.
Methodology: This randomized clinical control study was conducted in the department of Cardiothracic Anesthesia
PGMI/LRH from April 2012 to December 2014. A totol number of 100 patients were randomly assigned in one of the
two groups,i-e 50 in GIK (glucose,Insulin,Potassium) and 50 patients in control group. Patients’s demographic data,and
the effect of glycemic control during and after cardiac surgery on clinical outcome was recorded and compared in the
two groups. Calculations were done using the SPSS,software pakage,version17.
Results: The duration of mechanical ventilation (6.2 ± 1.02 hours GIK versus 8.5 ± 21.9 hours contol group, P < 0.05
and length of stay in the ICU (intensive care unit) was 47 ± 4.45 hours GIK versus control group 62.71±2.79 hours,
P< 0.05 (Significat).
Conclusion: The results from this study suggest that tight glycaemic control during and after cardiac surgery significantly
reduces , the duration of mechanical ventilation and length of stay in the ICU (intensive care unit) in patients
undergoing CABG surgery. However, further research needs to be done to provide a definitive answer on the benefits
of glycaemic control for cardiac surgery patients.
Key words: Glycemic control, CABG surgery, Cardiac surgery